AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 5, 2025,
(HIMS) experienced a significant decline, with its trading volume reaching $19.51 billion, a 41.22% decrease from the previous day. The stock price fell by 1.57%, marking the third consecutive day of decline, with a total decrease of 7.05% over the past three days.Hims & Hers Health has announced its acquisition of
, a leading European digital health company. This strategic move aims to expand the company's presence into Germany, France, and Ireland, furthering its personalized digital health initiatives. The acquisition is part of & Hers' broader strategy to enhance its global footprint and drive growth.Hims & Hers Health has been actively pursuing acquisitions to strengthen its market position. The company recently raised $1 billion in capital, which it is using to acquire ZAVA. This acquisition is expected to boost Hims & Hers' revenue and expand its international market reach by 2026.
Analysts have responded positively to Hims & Hers' acquisition of ZAVA. Needham analyst Ryan MacDonald reiterated a Buy rating on the stock, highlighting the potential for significant growth and expansion in the European market. The acquisition is seen as a strategic move that will drive long-term value for shareholders.
Hunt down the stocks with explosive trading volume.

Dec.30 2025

Dec.30 2025

Dec.30 2025

Dec.30 2025

Dec.30 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet